Browsing by Author "Kuran, B"

Now showing 1 - 6 of 6
  • No Thumbnail Available
    Item
    Assessment of the Relationship Between Vitamin D Level and Non-specific Musculoskeletal System Pain: A Multicenter Retrospective Study (Stroke Study Group)
    Karahan, AY; Hüner, B; Kuran, B; Sezer, N; Çelik, C; Salbas, E; Ordahan, B; Karaca, G; Yilmaz, H; Gündüz, B; Erhan, B; Bugdayci, DS; Bardak, A; Paker, N; Külcü, DG; Yaliman, A; Atalay, NS; Yildiz, N; Icagasioglu, A; Basaran, S; Tikiz, C; Kaydok, E; Kaya, T; Karatas, GK; Baygutalp, F; Celebi, G; Yilmaz, F; Önes, K; Akkus, S; Yumusakhuylu, Y; Durlanik, G; Dogu, B; Öncü, J; Sari, A; Özkan, FÜ; Kaysin, MY; Taskiran, ÖÖ; Erol, AM; Eskiyurt, N
    Objective: In this study, it was aimed to evaluate the relationship between vitamin D level and pain severity, localization and duration in patients with non-specific musculoskeletal pain. Materials and Methods: Patients who applied to physical medicine and rehabilitation outpatient clinics due to non-specific muscle pain in 19 centers in Turkey were retrospectively screened. Three thousand four hundred fourpatients were included in the study, whose pain level was determined by visual analog scale (VAS) and the painful region, duration of pain and vitamin D level were reached. D group was found to be D deficient (group 1) when 25 (OH) D level was 20 ng/mL or less and group D 2 (vitamin D deficiency) was higher than 30 ng/mL (group 3). The groups were compared in terms of pain duration, localization and severity. In addition, the correlations of pain localization, severity and duration with vitamin D levels were examined. Results: D vitamin deficiency was detected in 2202 (70.9%) of 3 thousand four hundred and four registered patients, and it was found that vitamin D deficiency in 516 (16.6%) and normal vitamin D in 386 (12.4%). The groups were similar in terms of age, body mass index, income level, duration of complaint, education level, family type and working status (p>0.05). There was no statistically significant difference between groups in terms of VAS, pain localization and duration scores (p>0.05). Conclusion: Our study shows that vitamin D deficiency in patients with nonspecific musculoskeletal pain is not associated with the severity and duration of pain.
  • No Thumbnail Available
    Item
    Demographic and clinical characteristics of inpatient stroke patients in Turkey
    Külcü, DG; Kuran, B; Karahan, AY; Özgirgin, N; Basaran, S; Yaliman, A; Savas, S; Tikiz, C; Aktas, I; Bardak, A; Tuncer, T; Yilmaz, F; Erhan, B; Sirzai, H; Çelik, B; Durlanik, G; Dogu, B; Öncü, J; Hüner, B; Öztürk, G; Eskiyurt, N; Akpinar, FM; Özkan, FU; Paker, N; Bugdayci, DS; Gündüz, B; Satir, Ö; Atalay, NS; Yildiz, N; Altindag, Ö; Demir, SE; Kaya, E; Uçar, D; Sari, A; Karatas, GK; Taskiran, ÖÖ
    Objectives: This study aims to assess the stroke rehabilitation facilities provided by university hospitals (UHs) and training and research hospitals (TRHs) and to evaluate the geographical disparities in stroke rehabilitation. Patients and methods: Between April 2013 and April 2014 a total of 1,529 stroke patients (817 males, 712 females; mean age: 61.7 +/- 14.0 years; range, 12 to 91 years) who were admitted to the physical medicine and rehabilitation clinics in 20 tertiary care centers were retrospectively analyzed. Demographic, regional and clinical characteristics, details of rehabilitation period, functional status, and complications were collected. Results: The median duration of stroke was five (range, 1 to 360) months. The ratio of the patients treated in the TRH in the Marmara region was 77%, but only 25% of the patients were living in the Marmara region. Duration of hospitalization was longer in the TRHs with a median of 28 days compared to those of UHs (median: 22 days) (p<0.0001). More than half of the patients (55%) were rehabilitated in the Marmara region. Time after stroke was the highest in the Southeast region with a median of 12 (range, 1 to 230) months and the lowest in the Aegean region with a median of four (range, 1 to 84) months. Conclusion: This study provides an insight into the situation of stroke rehabilitation settings and characteristics of stroke patients in Turkey. A standard method of patient evaluation and a registry system may provide data about the efficacy of stroke rehabilitation and may help to focus on the problems that hinder a better outcome.
  • No Thumbnail Available
    Item
    Assessment of the Relationship Between Vitamin D Level and Non-specific Musculoskeletal System Pain: A Multicenter Retrospective Study (Stroke Study Group) (vol 23, pg 61, 2017)
    Karahan, AY; Hüner, B; Kuran, B; Sezer, N; Çelik, C; Salbas, E; Ordahan, B; Karaca, G; Yilmaz, H; Gündüz, B; Erhan, B; Bugdayci, DS; Bardak, A; Paker, N; Külcü, DG; Yaliman, A; Atalay, NS; Yildiz, N; Içagasioglu, A; Basaran, S; Tikiz, C; Kaydok, E; Kaya, T; Karatas, GK; Baygutalp, F; Çelebi, G; Yilmaz, F; Önes, K; Akkus, S; Yumusakhuylu, Y; Durlanik, G; Dogu, B; Öncü, J; Sari, A; Özkan, FU; Kaysin, MY; Taskiran, OO; Erol, AM; Eskiyurt, N
  • No Thumbnail Available
    Item
    THE FREQUENCY AND ASSOCIATION OF KNEE, HIP, HAND AND SPINE OSTEOARTHRITIS IN TURKISH POPULATION: A PRELIMINARY RE PORT OF MULTICENTER LONGITUDINAL STUDY
    Tuncer, T; Ugur, S; Nur, H; Kacar, C; Akarimak, U; Altan, L; Ayhan, F; Bal, A; Basaran, S; Bilgilisoy, M; Bozbas, G; Cerrahoglu, L; Cevik, R; Coskun, N; Dagli, Z; Durmaz, B; Duruoz, T; Dulgeroglu, D; Gurer, G; Gursoy, S; Hepguler, S; Hizmetli, S; Kaplanoglu, E; Kaya, T; Kocabas, H; Kuran, B; Melikoglu, M; Nas, K; Oncu, J; Ozcakir, S; Ozdolap, S; Saridogan, M; Sarikaya, S; Sindel, D; Sahin, O; Sendur, OF; Tikiz, C; Ugurlu, H; Yilmaz, F
  • No Thumbnail Available
    Item
    Stroke risk in patients with musculoskeletal pain: A multicenter prospective Turkish trial
    Kuran, B; Kulcu, DG; Huner, B; Karahan, A; Yaliman, A; Celik, B; Içagasioglu, A; Celik, C; Tikiz, C; Basaran, S
  • No Thumbnail Available
    Item
    Prevalence of Rheumatoid Arthritis and Spondyloarthritis in Turkey: A Nationwide Study
    Tuncer, T; Gilgil, E; Kaçar, C; Kurtais, Y; Kutlay, S; Bütün, B; Yalçin, P; Akarirmak, Ü; Altan, L; Ardiç, F; Ardiçoglu, Ö; Altay, Z; Cantürk, F; Cerrahoglu, L; Çevik, R; Demir, H; Durmaz, B; Dursun, N; Duruöz, T; Erdogan, C; Evcik, D; Gürsoy, S; Hizmetli, S; Kaptanoglu, E; Kayhan, Ö; Kirnap, M; Kokino, S; Kozanoglu, E; Kuran, B; Nas, K; Öncel, S; Sindel, D; Orkun, S; Sarpel, T; Savas, S; Sendur, OF; Senel, K; Ugurlu, H; Uzunca, K; Tekeoglu, I; Guillemin, F
    Objectives: This study aims to estimate the prevalence of rheumatoid arthritis (RA) and spondyloarthritis (SpA) in Turkey using the same telephone questionnaire developed for screening RA and SpA in France and used in Serbia and Lithuania. Material and methods: The study was performed in two steps. In step I, the French questionnaire was translated into Turkish and validated through a group of 200 patients (80 males, 120 females; mean age 44.0 +/- 13.1 years; range, 19 to 75 years) followed up at the rheumatology departments of University Hospitals in Antalya and Ankara. In step II, the validated Turkish questionnaire was administered face-to-face to randomly selected 4,012 subjects (1,670 males, 2,342 females; mean age 41.5 +/- 16.8 years; range, 16 to 97 years) by trained general practitioners across the country, in 25 provinces for case detection. The subjects who were suspected of having RA or SpA in accordance with the questionnaire were invited to the nearest university hospital for rheumatologic examination in order to confirm the diagnosis. Results: In step II, a total of 25 subjects (2 males, 23 females) were diagnosed as RA. The standardized RA prevalence for the general population of Turkey was calculated as 0.56% (95% confidence interval [CI]; 0.33-0.79), 0.10% (95% CI; -0.05-0.25) for males and 0.89% (95% CI; 0.51-1.27) for females. A total of 18 subjects (3 males, 15 females) were diagnosed as SpA. The standardized SpA prevalence for the general population of Turkey was 0.46% (95% CI; 0.25-0.67), 0.17% (95% CI; -0.03-0.37) for males and 0.65% (95% CI; 0.32-0.98) for females. The prevalence of RA was highest in the Northern region (2.00%) and the prevalence of SpA was highest in the Central region (1.49%). Conclusion: The prevalences of RA and SpA in Turkey are close to each other and there are significant inter-regional variations in prevalences of both RA and SpA.